NASDAQ: SNGXSoligenix Inc Stock Ownership - Who owns Soligenix?
Insider buying vs selling
Have Soligenix Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christopher J. Schaber | CHAIRMAN CEO AND PRESIDENT | 2025-10-02 | 15,132 | $1.32 | $20.00kBuy |
SNGX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SNGX insiders and whales buy or sell their stock.
SNGX Shareholders
What type of owners hold Soligenix Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Claudio Cavazza | 365.81% | 54,227,816 | $20.66M | Insider |
| Bam Management LLC | 145.75% | 21,606,092 | $8.23M | Insider |
| Biotex Pharma Investments LLC | 119.16% | 17,665,000 | $6.73M | Insider |
| Cyrille F. Buhrman | 33.05% | 4,900,020 | $1.87M | Insider |
| Mark E. Pearson | 17.39% | 2,578,338 | $982.35k | Insider |
| Randal J. Kirk | 10.53% | 1,560,298 | $594.47k | Insider |
| Steve H. Kanzer | 8.65% | 1,282,203 | $488.52k | Insider |
| Spa Essetifin | 1.98% | 293,510 | $111.83k | Insider |
| Evan Myrianthopoulos | 1.52% | 224,780 | $85.64k | Insider |
| Paolo Cavazza | 1.51% | 223,685 | $85.22k | Insider |
SNGX vs Biotech Stocks
Soligenix Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.